| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.002 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.004 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.005 |